Of Mice and Men
About one million Americans carry the hepatitis B virus (HBV) which can lead to liver cancer. But the search for treatments has been stymied by the lack of a suitable animal for testing new drugs. Rodents don’t get HBV, and chimpanzees, which do, are expensive.
XTL Biopharmacueticals in Rehovot, Israel, has come up with a solution by creating a mouse with a bit of human liver inside it. XTL’s recipe: destroy the immune system of a normal mouse with gamma rays. Next, transplant a peppercorn-sized fragment of HBV-infected human liver, along with bone marrow from an immune-deficient mouse. XTL calls the resulting creature a “trimera” because it has components of three different animals. Since the mouse’s weak immune system doesn’t reject the human cells, there is time to test the effects of anti-viral drugs. XTL hopes to develop trimera models for cancer.
Keep Reading
Most Popular
Large language models can do jaw-dropping things. But nobody knows exactly why.
And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
The problem with plug-in hybrids? Their drivers.
Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.